dysfunction, and death during the long-term postoperative course.1-'3 These same indexes, when applied in the initial evaluation of asymptomatic patients, provide valuable insights regarding the likelihood that symptoms or left ventricular dysfunction, or both, will develop over the course of the next 4-5 years.14 Therefore, data obtained on initial evaluation may be used to predict the need for valve replacement in the near future. However, during the long-term natural history of asymptomatic aortic regurgitation, it is likely that the rate and magnitude of changes in left ventricular size and function, as well as those measurements made initially, determine the subsequent clinical outcome. The impact of changes in left ventricular dimensions and systolic 1626 Circulation Vol 84, No 4 October 1991 function on the clinical course of untreated asymptomatic patients has not been investigated. In this report, we extend our previous observations on the natural history of chronic aortic regurgitation14 to include a larger number of patients with longer follow-up periods in order to examine the relation between serial long-term changes in left ventricular function and clinical outcome in asymptomatic patients with this disease.
Methods

Patient Selection
We studied 104 consecutive asymptomatic patients with severe chronic aortic regurgitation between January 1973 and March 1988 who fulfilled echocardiographic and radionuclide angiographic criteria of normal resting left ventricular systolic function for our laboratory. There were 89 men and 15 women ranging in age from 17 to 67 years (mean, 36 years). On entry into the study, all patients had echocardiographic fractional shortening of 29% or greater. Radionuclide angiography became available in our institution for clinical investigation in 1976; all patients entering the study after August 1976 had normal ejection fractions under resting conditions (45% or greater15) on initial evaluation. Twenty-five patients entered the study before August 1976 but subsequently had radionuclide angiograms in 1976 or thereafter demonstrating normal resting ejection fractions. In two of these latter patients, the first radionuclide angiogram demonstrating normal left ventricular ejection fraction was performed after the development of symptoms warranting valve replacement surgery (after asymptomatic follow-up periods of 30 and 49 months), and this radionuclide angiogram was used as a preoperative study.
Cardiac catheterization was performed in 85 of the 104 patients and confirmed isolated severe aortic regurgitation in 81 patients, with 3 + to 4+ out of a maximum of 4+ valvular regurgitation visualized by aortic root cineangiography. Three patients had small ventricular septal defects with left-to-right shunt ratios of less than 1.5:1. One patient had associated mitral regurgitation; this patient subsequently developed symptoms and was found at operation to have only minimal mitral regurgitation that did not require concomitant mitral valve replacement. Coronary arteriography was not performed in the asymptomatic patients with normal left ventricular function but was performed preoperatively in patients who subsequently underwent operation if they were more than 35 years of age or if they complained of angina pectoris. Two patients had coronary artery disease at preoperative coronary arteriography; one patient had greater than 50% but less than 75% stenosis of the right coronary artery, and another had greater than 75% stenosis of the left anterior descending coronary artery. Neither of these two patients, nor any other patient in this series, had evidence of myocardial infarction before or during the study. The 19 patients not catheterized all had physical findings compatible with severe isolated aortic regurgitation and systemic pulse pressures of 70 mm Hg or greater. No patient had evidence of primary aortic root disease.
Echocardiography
Echocardiographic studies were performed as previously described.514 Measurements of left ventricular transverse dimensions were obtained with the ultrasound beam directed through the left ventricle just caudal to the tips of the mitral leaflets.5,16 The end-diastolic left ventricular dimension was measured at the R wave of the electrocardiogram, and the end-systolic dimension was measured at the peak of systolic posterior wall motion. Left ventricular fractional shortening was calculated as the ratio of the difference between the left ventricular diastolic and systolic dimensions to the end-diastolic dimension. Interventricular septal thickness was measured just below the tips of the mitral leaflets, and left ventricular posterior wall thickness was measured at the level of the mitral leaflets.
Gated Blood Pool Cardiac Scintigraphy
Gated equilibrium radionuclide angiography was performed with patients in the supine position at rest and during maximum symptom-limited supine bicycle exercise. Left ventricular ejection fraction was computed from the scintigraphic data as previously described.1"'13 '15 Exercise studies were performed with a bicycle ergometer and a restraining harness to minimize patient motion under the Anger camera. Exercise loads were increased by 25-W increments every 2 minutes until the development of limiting fatigue or dyspnea. Heart rate and blood pressure (by cuff sphygmomanometry) were monitored during exercise. Imaging was begun shortly after the onset of exercise, but only that portion of the data series corresponding to the final 2-2.5 minutes of maximal exercise was selected for analysis.
Serial Follow-up Studies
After completion of initial studies, patients were followed by their referring physicians and by the Cardiology Clinic of the National Heart, Lung, and Blood Institute (NHLBI). Outpatient reevaluations at the NHLBI were performed on a yearly basis in most patients. When possible, patients with more severely dilated left ventricles (end-diastolic dimension >75 mm or end-systolic dimension >50 mm) were reevaluated every 6 months. The frequency of repeat evaluations varied in many patients and was often individualized, depending upon the severity of left ventricular dilatation and the level of systolic function, as well as upon personal hardships encountered in travelling repeatedly to our clinic. At each evaluation, a history and cardiac physical examination, chest radiograph, electrocardiogram, echocardiogram, and radionuclide angiogram were obtained, with the exception that radionuclide angiography was performed on a yearly basis in those patients who were reevaluated at 6-month intervals. Serial studies in the 104 patients included a total of 815 echocardiograms (average, 7.8 per patient) and 515 radionuclide angiograms (average, 5.0 per patient) over a follow-up period ranging from 2 to 16 years (mean, 8 years). All 104 patients had at least three echocardiographic (range, 3-32) and three radionuclide angiographic (range, 3-15) studies, with the exception of the two patients noted above in whom only a single radionuclide study was performed on a preoperative basis.
Initial echocardiographic and radionuclide angiographic studies were performed while patients were taking no cardiac medications, except for one patient who was studied while receiving digoxin and propranolol. During the course of the study, we recommended that patients receive no cardiac drugs except for antiarrhythmic drugs in those patients with evidence of ventricular or supraventricular tachyarrhythmias. After entry into the study, five patients were placed on digoxin by their referring physicians and another two patients were placed on hydralazine. In these seven patients, follow-up data over 7-61 months were obtained before these drugs were instituted; late studies over 34-100 months were repeated while these patients were on either digoxin or hydralazine. Initial data. The relation between initial echocardiographic measurements and radionuclide angiographic data was assessed using linear regression analysis. The association between individual echocardiographic and radionuclide angiographic variables obtained at initial study and subsequent clinical course was tested using the univariate Cox regression model.18 Multivariate Cox regression analyses of these data were also performed. Two separate sets of computations were performed. In one, the end point evaluated was death or the development of symptoms; in the other, the end point was defined as death, the onset of symptoms, or the onset of left ventricular dysfunction without symptoms.
To further assess the influence of baseline variables on subsequent outcome, patients were divided into subgroups using threshold values of end-diastolic dimension, end-systolic dimension, and the magnitude of change in ejection fraction during exercise, as previously described.' 4 Life table curves were plotted for all patients and for these subgroups of patients using a modification of the method of Kaplan Figure 2 .
Serial data inpatient subgroups. The impact of serial changes in end-systolic dimension and rest ejection fraction was further assessed within patient subgroups defined by the magnitude of the baseline end-systolic dimension. In the subgroup of patients with an end-systolic dimension 50 mm or more on (Table 3 ). This observation may be explained by the significant relation between these exercise indexes and the severity of left ventricular cavity dilatation under resting conditions (Figure 3 ). Both the end-diastolic dimension and the end-systolic dimension correlated with the exercise ejection fraction (r= -0.49 and r= -0.61, respectively, both p<0.001) and the change in ejection fraction from resting values (r= -0.44 and r=-0.46, respectively, both p<0.001). Although serial decreases in the ejection fraction at rest were significantly associated with subsequent cardiac events, serial changes in the exercise ejection fraction response were not (Table 3) .
Asymptomatic Left Ventricular Dysfunction
The data in the four patients who underwent operation because of the development of left ventricular dysfunction in the absence of symptoms are shown in Table 4 . These four patients manifested reductions in fractional shortening and resting ejection fraction during serial studies, which were associated with an increase in left ventricular endsystolic dimension, during follow-up periods ranging from 28-80 months. After operation, substantial reductions in left ventricular end-diastolic dimension and increases in ejection fraction were observed in all four patients.
Sudden Death
The two patients who died during the course of this study were both young men (ages 32 and 40 years at the time of death), in whom sudden death occurred during sedentary activities after 31 and 84 months of follow-up. Postmortem examination revealed no evidence of coronary artery disease. In both patients, fractional shortening and ejection frac- 39  59  62  80  75  58  23  43  57  53  65  62  2  41  76  54  29  46  37  28  78  59  24  42  36  58  52  49  3  47  62  42  32  47  33  44  72  55  24  43  26  43  65  49  4  48  74  51  31  61  45  36  77  58  25  45  32  50  66  57 EDD, end-diastolic dimension; ESD, end-systolic dimension; FS, fractional shortening; EFR, ejection fraction at rest; EFEX ejection fraction during exercise. tion were consistently maintained in the normal range before death. These data and echocardiographic dimensions remained stable without serial change during multiple serial studies ( Figure 4 ). The exercise ejection fraction response was not distinctly abnormal before death in either patient, increasing by 1% and 2% compared to the resting value in the last exercise radionuclide angiogram before death.
The data obtained at the initial evaluation of these two patients are presented in Figure 5 in comparison with the other 102 patients. Regarding the initial ejection fraction data, the two patients who ultimately died did not differ from the other patients with respect to either the ejection fraction at rest or its change with exercise. On the other hand, the left ventricular cavity dimensions in these two patients were at the extreme end of the spectrum. Both had end-diastolic dimensions that were consistently 80 mm or greater and end-systolic dimensions that were 55 mm or greater. Only one other surviving patient in this series had ventricular dimensions in this range.
Postoperative Studies
Among the 23 patients who underwent aortic valve replacement, there were no perioperative or postoperative deaths. Despite subnormal ejection fractions at rest in 15 patients (65%) preoperatively, ejection fractions were normal in all patients at the 6-8-month postoperative reevaluation, and for the group ejection fraction increased significantly after operation both at rest (from 45±5 to 60+11%,p<0.001) and during exercise (from 36+8 to 57±13%,p<0.001). In concert with the increases in left ventricular systolic function, there was a concomitant decrease in left ventricular end-diastolic dimension after operation (from 74±4 to 52±6 mm, p<0.001). The current study also provides several new observations on the natural history of asymptomatic chronic aortic regurgitation that were not possible in previous studies. The larger sample size (with a greater number of cardiac end points) in the current study compared to our previous experience permitted a multivariate Cox regression analysis of the initial functional measurements relative to outcome, and the longer duration of follow-up permitted analysis of the importance of serial changes in left ventricular dimensions and function.
Left ventricular dimensions versus exercise ejection fraction. These analyses confirm the importance of echocardiographic estimates of the severity of left ventricular cavity dilatation in the risk stratification of such patients. However, the measurements of left ventricular systolic function during exercise, although significantly associated with outcome when assessed in a univariate Cox regression analysis, were not independent predictors of outcome when subjected to a multivariate analysis that also incorporated the left ventricular cavity dimensions determined at rest by echocardiography (Table 3 ). The explanation for this effect appears to be the significant correlation between left ventricular dilatation and the exercise functional measurements: both the ejection fraction during exercise and the magnitude of change in ejection fraction from rest to exercise were significantly related to the severity of left ventricular dilatation as reflected by the left ventricular dimensions at end diastole and end systole (Figure 3 ). The ejection fraction may be influenced dramatically by sudden changes in ventricular loading that develop during exercise22,23 as the regurgitant volume decreases with exercise in response to peripheral vasodilation and reduced diastolic filling periods,23'24 and patients with the most severe volume overload may also be subject to the greatest alteration in loading with exercise.23,24 With these considerations in mind, we do not believe that serial measurement of the ejection fraction during exercise is warranted in asymptomatic patients.
Serial changes in left ventricularfunction. During the course of serial studies, the rate of change of virtually every measure of left ventricular function was significantly associated with death or the development of symptoms when these changes were assessed in a univariate analysis. When subjected to a multivariate Cox regression evaluation, which also included those measurements made on initial study, both the rate of increase in end-systolic dimension and the rate of decrease in resting ejection fraction provided additional independent predictive information beyond that provided by age and the baseline end-systolic dimension (Table 3) .
From our data it is difficult to define a specific rate of change in either end-systolic dimension or 
Sudden Death
In our previous experience14 and that of Siemienczuk et al,21 no deaths occurred during the conservative management of asymptomatic patients with aortic regurgitation and normal left ventricular systolic function. In the larger experience of the current study, two patients died suddenly with longer-term follow-up, both during sedentary activities. Despite these events, our data continue to indicate that sudden death is a rare occurrence among patients with chronic aortic regurgitation with normal left ventricular systolic function in that the two deaths in this series represent an annual mortality rate of only 0.4% per year.
Although the mechanisms responsible for these deaths cannot be determined with certainty, inferences can nonetheless be made. Left ventricular systolic function was normal in both of these patients, but both had extreme degrees of ventricular dilatation on repeated studies with end-diastolic dimensions of 80 mm or greater and end-systolic dimensions of 55 mm or greater (Figure 4 ). Only one other patient in this series had left ventricular dimensions in this range ( Figure 5 ). In our experience, preserved systolic performance in such severely dilated ventricles is an uncommon finding, as patients with this degree of ventricular dilatation usually have evidence of left ventricular systolic dysfunction.5"1' This presumably occurs because the severely dilated ventricle has exceeded its preload reserve and is unable to maintain normal ejection performance in the setting of heightened afterload.25-27 The few patients in whom systolic function is maintained in the normal range despite such severe ventricular dilatation might be at risk of sudden cardiac death on the basis of the inability to compensate for sudden increases in afterload by further chamber dilatation, with resultant acute heart failure. Alternatively, the greatly increased wall stress might predispose to subendocardial ischemia and associated ventricular arrhythmias.
That two of the three asymptomatic patients in our series with the most severe left ventricular dilatation died suddenly appears similar to the experience of Turina et al,28 who also reported sudden and unexplained deaths in two asymptomatic patients who were awaiting aortic valve replacement, both of whom had severe ventricular dilatation (end-diastolic volume index >200 ml/m2). It is not certain whether these two latter patients had normal or depressed systolic function before death. The reported deaths in our series and those of 
Asymptomatic Left Ventricular Dysfunction
A final observation of our study is that the development of left ventricular dysfunction in chronic aortic regurgitation in the absence of symptoms is also a relatively uncommon event. The concern that such left ventricular dysfunction may develop in asymptomatic patients arises from numerous studies demonstrating that by the time symptoms sufficiently severe as to warrant operation occur, a subset of patients will have already developed irreversible left ventricular dysfunction and will be at risk of persistent dysfunction and death from congestive heart failure during the long-term postoperative course.1-'3 Although this concern is well-founded, it reflects the cross-sectional experience of patients referred to tertiary centers for aortic valve replacement. A longitudinal evaluation of asymptomatic patients provides a different perspective. In our longitudinal analysis of asymptomatic patients, none of whom initially were candidates for operation, only four of
